Cargando…

Case report: Remission of chronic low back pain and oral dysesthesia comorbid with attention deficit/hyperactivity disorder by treatment with atomoxetine and pramipexole

INTRODUCTION: Oral dysesthesia is a disease characterized by pain and/or abnormal sensations in the oral region, without any organic abnormality. Its symptoms include pain, and it is considered to be a disorder associated with idiopathic oral-facial pain. It is also known that idiopathic oral-facial...

Descripción completa

Detalles Bibliográficos
Autores principales: Kasahara, Satoshi, Kato, Yuichi, Takahashi, Miwako, Matsudaira, Ko, Sato, Naoko, Niwa, Shin-Ichi, Momose, Toshimitsu, Uchida, Kanji
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10277465/
https://www.ncbi.nlm.nih.gov/pubmed/37342213
http://dx.doi.org/10.3389/fpain.2023.1159134
_version_ 1785060286989860864
author Kasahara, Satoshi
Kato, Yuichi
Takahashi, Miwako
Matsudaira, Ko
Sato, Naoko
Niwa, Shin-Ichi
Momose, Toshimitsu
Uchida, Kanji
author_facet Kasahara, Satoshi
Kato, Yuichi
Takahashi, Miwako
Matsudaira, Ko
Sato, Naoko
Niwa, Shin-Ichi
Momose, Toshimitsu
Uchida, Kanji
author_sort Kasahara, Satoshi
collection PubMed
description INTRODUCTION: Oral dysesthesia is a disease characterized by pain and/or abnormal sensations in the oral region, without any organic abnormality. Its symptoms include pain, and it is considered to be a disorder associated with idiopathic oral-facial pain. It is also known that idiopathic oral-facial pain tends to coexist with chronic musculoskeletal pain, including low back pain, even before its onset. Such coexisting idiopathic pain conditions are also called chronic overlapping pain conditions (COPCs). In general, COPCs are often refractory to treatment. Recently, it has been reported that attention deficit hyperactivity disorder (ADHD) is associated with many COPCs, such as pain in the facial and lower back regions and so on. However, there are no reports of (1) ADHD as a comorbidity with oral dysesthesia (OD) or (2) of the therapeutic effects of ADHD medications or dopamine agonists on low back pain and OD or an (3) evaluation of cerebral blood flow over time after treatment with these medications for OD and low back pain. CASE PRESENTATION: In this study, we report the case of an 80-year-old man with OD and chronic low back pain that persisted for more than 25 years. His OD and chronic back pain were refractory to standard treatment, prevented him from continuing work, and tended to be exacerbated by conflicts in his relationship with his son. In recent years, ADHD has often been found to be comorbid with chronic pain, and ADHD medications have been reported to improve chronic pain as well. The patient was confirmed to have undiagnosed ADHD and was treated with the ADHD medication atomoxetine and dopamine agonist pramipexole, which dramatically improved his OD, chronic back pain, and cognitive function. Furthermore, along the course of treatment, there was improvement in cerebral blood flow in his prefrontal cortex, which was thought to reflect improved function in the region. Consequently, he was able to resume work and improve his family relationships. CONCLUSION: Therefore, in the cases of ODs and COPCs, screening for ADHD and, if ADHD is diagnosed, ADHD medications or dopamine agonists may be considered.
format Online
Article
Text
id pubmed-10277465
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-102774652023-06-20 Case report: Remission of chronic low back pain and oral dysesthesia comorbid with attention deficit/hyperactivity disorder by treatment with atomoxetine and pramipexole Kasahara, Satoshi Kato, Yuichi Takahashi, Miwako Matsudaira, Ko Sato, Naoko Niwa, Shin-Ichi Momose, Toshimitsu Uchida, Kanji Front Pain Res (Lausanne) Pain Research INTRODUCTION: Oral dysesthesia is a disease characterized by pain and/or abnormal sensations in the oral region, without any organic abnormality. Its symptoms include pain, and it is considered to be a disorder associated with idiopathic oral-facial pain. It is also known that idiopathic oral-facial pain tends to coexist with chronic musculoskeletal pain, including low back pain, even before its onset. Such coexisting idiopathic pain conditions are also called chronic overlapping pain conditions (COPCs). In general, COPCs are often refractory to treatment. Recently, it has been reported that attention deficit hyperactivity disorder (ADHD) is associated with many COPCs, such as pain in the facial and lower back regions and so on. However, there are no reports of (1) ADHD as a comorbidity with oral dysesthesia (OD) or (2) of the therapeutic effects of ADHD medications or dopamine agonists on low back pain and OD or an (3) evaluation of cerebral blood flow over time after treatment with these medications for OD and low back pain. CASE PRESENTATION: In this study, we report the case of an 80-year-old man with OD and chronic low back pain that persisted for more than 25 years. His OD and chronic back pain were refractory to standard treatment, prevented him from continuing work, and tended to be exacerbated by conflicts in his relationship with his son. In recent years, ADHD has often been found to be comorbid with chronic pain, and ADHD medications have been reported to improve chronic pain as well. The patient was confirmed to have undiagnosed ADHD and was treated with the ADHD medication atomoxetine and dopamine agonist pramipexole, which dramatically improved his OD, chronic back pain, and cognitive function. Furthermore, along the course of treatment, there was improvement in cerebral blood flow in his prefrontal cortex, which was thought to reflect improved function in the region. Consequently, he was able to resume work and improve his family relationships. CONCLUSION: Therefore, in the cases of ODs and COPCs, screening for ADHD and, if ADHD is diagnosed, ADHD medications or dopamine agonists may be considered. Frontiers Media S.A. 2023-06-05 /pmc/articles/PMC10277465/ /pubmed/37342213 http://dx.doi.org/10.3389/fpain.2023.1159134 Text en © 2023 Kasahara, Kato, Takahashi, Matsudaira, Sato, Niwa, Momose and Uchida. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY) (https://creativecommons.org/licenses/by/4.0/) . The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Pain Research
Kasahara, Satoshi
Kato, Yuichi
Takahashi, Miwako
Matsudaira, Ko
Sato, Naoko
Niwa, Shin-Ichi
Momose, Toshimitsu
Uchida, Kanji
Case report: Remission of chronic low back pain and oral dysesthesia comorbid with attention deficit/hyperactivity disorder by treatment with atomoxetine and pramipexole
title Case report: Remission of chronic low back pain and oral dysesthesia comorbid with attention deficit/hyperactivity disorder by treatment with atomoxetine and pramipexole
title_full Case report: Remission of chronic low back pain and oral dysesthesia comorbid with attention deficit/hyperactivity disorder by treatment with atomoxetine and pramipexole
title_fullStr Case report: Remission of chronic low back pain and oral dysesthesia comorbid with attention deficit/hyperactivity disorder by treatment with atomoxetine and pramipexole
title_full_unstemmed Case report: Remission of chronic low back pain and oral dysesthesia comorbid with attention deficit/hyperactivity disorder by treatment with atomoxetine and pramipexole
title_short Case report: Remission of chronic low back pain and oral dysesthesia comorbid with attention deficit/hyperactivity disorder by treatment with atomoxetine and pramipexole
title_sort case report: remission of chronic low back pain and oral dysesthesia comorbid with attention deficit/hyperactivity disorder by treatment with atomoxetine and pramipexole
topic Pain Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10277465/
https://www.ncbi.nlm.nih.gov/pubmed/37342213
http://dx.doi.org/10.3389/fpain.2023.1159134
work_keys_str_mv AT kasaharasatoshi casereportremissionofchroniclowbackpainandoraldysesthesiacomorbidwithattentiondeficithyperactivitydisorderbytreatmentwithatomoxetineandpramipexole
AT katoyuichi casereportremissionofchroniclowbackpainandoraldysesthesiacomorbidwithattentiondeficithyperactivitydisorderbytreatmentwithatomoxetineandpramipexole
AT takahashimiwako casereportremissionofchroniclowbackpainandoraldysesthesiacomorbidwithattentiondeficithyperactivitydisorderbytreatmentwithatomoxetineandpramipexole
AT matsudairako casereportremissionofchroniclowbackpainandoraldysesthesiacomorbidwithattentiondeficithyperactivitydisorderbytreatmentwithatomoxetineandpramipexole
AT satonaoko casereportremissionofchroniclowbackpainandoraldysesthesiacomorbidwithattentiondeficithyperactivitydisorderbytreatmentwithatomoxetineandpramipexole
AT niwashinichi casereportremissionofchroniclowbackpainandoraldysesthesiacomorbidwithattentiondeficithyperactivitydisorderbytreatmentwithatomoxetineandpramipexole
AT momosetoshimitsu casereportremissionofchroniclowbackpainandoraldysesthesiacomorbidwithattentiondeficithyperactivitydisorderbytreatmentwithatomoxetineandpramipexole
AT uchidakanji casereportremissionofchroniclowbackpainandoraldysesthesiacomorbidwithattentiondeficithyperactivitydisorderbytreatmentwithatomoxetineandpramipexole